The NxStage Scientific Advisory Board for Critical Care is a community of world class science and medical experts that advise NxStage on clinical considerations as we continue to develop our next generations of products.
This board of experts also helps highlight new industry trends and educational priorities for healthcare providers and staff. These health care professionals are dedicated to improving care in our industry and share in the NxStage vision of advancing the delivery of renal care.
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.